Latest filing published 09 Dec 2025 for Adverum Biotechnologies, Inc., €13.1M.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Frazier Life Sciences Public Fund, L.P.: trading record in brief
This profile gathers the share dealings of Frazier Life Sciences Public Fund, L.P. across 2 companies, led by Adverum Biotechnologies, Inc. and Viridian Therapeutics, Inc.\DE. We count 2 filings; the first trade dates from 23 September 2021 and the latest from 9 December 2025.
Purchases make up the whole of the open-market record (1 purchase, €1.9M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 9 December 2025 came the latest disclosure, a transaction for €13.1M in Adverum Biotechnologies, Inc. The last insider purchase was made public on 28 September 2021, 1,869 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Frazier Life Sciences Public Fund, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,288,949 shares@ US$3.56100.0% of flowCommon StockSEC:0001231919-25-000588:0
- 200,000 shares@ US$11.00100.0% of flowCommon StockSEC:0001209191-21-058002:0Canonical exit: 22 Dec 2021 (T+90)
2 of 2 declarations
